AVANCES EN LA PATOGENESIS Y TRATAMIENTO DE LAS HEPATOPATIAS METABOLICAS EN LA INFANCIA (PRIMERA PARTE)

J. Teckman; D. H. Perlmutter

AVANCES EN LA PATOGENESIS Y TRATAMIENTO DE LAS HEPATOPATIAS METABOLICAS EN LA INFANCIA (PRIMERA PARTE)

Translated title of the contribution: The progress in pathogenesis and treatment of metabolic hepatopathies in infants (first part)

J. Teckman, D. H. Perlmutter

Research output: Contribution to journal › Short survey › peer-review

Abstract

A considerable number of metabolic diseases cause liver injury in infants and children. In many cases, the liver is the sole organ clinically affected by the metabolic disease. Some of the diseases are relatively common. For instance, α₁-antitrypsin (α₁-AT) deficiency affects approximately 1 in 1800 live births. Moreover, taken together, the genetic/metabolic liver diseases account for approximately 30% of the 600 children who undergo liver transplantation each year.

Translated title of the contribution	The progress in pathogenesis and treatment of metabolic hepatopathies in infants (first part)
Original language	Spanish
Pages (from-to)	28-39
Number of pages	12
Journal	Practica Pediatrica
Volume	4
Issue number	11
State	Published - Dec 1 1995

Cite this

@article{9f3266f5df2443e1b7535c343c0f49db,

title = "AVANCES EN LA PATOGENESIS Y TRATAMIENTO DE LAS HEPATOPATIAS METABOLICAS EN LA INFANCIA (PRIMERA PARTE)",

abstract = "A considerable number of metabolic diseases cause liver injury in infants and children. In many cases, the liver is the sole organ clinically affected by the metabolic disease. Some of the diseases are relatively common. For instance, α1-antitrypsin (α1-AT) deficiency affects approximately 1 in 1800 live births. Moreover, taken together, the genetic/metabolic liver diseases account for approximately 30% of the 600 children who undergo liver transplantation each year.",

author = "J. Teckman and Perlmutter, {D. H.}",

year = "1995",

month = dec,

day = "1",

language = "Spanish",

volume = "4",

pages = "28--39",

journal = "Practica Pediatrica",

issn = "1405-1168",

number = "11",

}

TY - JOUR

T1 - AVANCES EN LA PATOGENESIS Y TRATAMIENTO DE LAS HEPATOPATIAS METABOLICAS EN LA INFANCIA (PRIMERA PARTE)

AU - Teckman, J.

AU - Perlmutter, D. H.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - A considerable number of metabolic diseases cause liver injury in infants and children. In many cases, the liver is the sole organ clinically affected by the metabolic disease. Some of the diseases are relatively common. For instance, α1-antitrypsin (α1-AT) deficiency affects approximately 1 in 1800 live births. Moreover, taken together, the genetic/metabolic liver diseases account for approximately 30% of the 600 children who undergo liver transplantation each year.

AB - A considerable number of metabolic diseases cause liver injury in infants and children. In many cases, the liver is the sole organ clinically affected by the metabolic disease. Some of the diseases are relatively common. For instance, α1-antitrypsin (α1-AT) deficiency affects approximately 1 in 1800 live births. Moreover, taken together, the genetic/metabolic liver diseases account for approximately 30% of the 600 children who undergo liver transplantation each year.

UR - http://www.scopus.com/inward/record.url?scp=0029587186&partnerID=8YFLogxK

M3 - Short survey

AN - SCOPUS:0029587186

SN - 1405-1168

VL - 4

SP - 28

EP - 39

JO - Practica Pediatrica

JF - Practica Pediatrica

IS - 11

ER -

AVANCES EN LA PATOGENESIS Y TRATAMIENTO DE LAS HEPATOPATIAS METABOLICAS EN LA INFANCIA (PRIMERA PARTE)

Abstract

Other files and links

Fingerprint

Cite this